CareDx, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $379.8M | $333.8M | $280.3M | $321.8M | $296.4M |
| Research and development | $71.4M | $72.5M | $82.4M | $90.4M | $76.5M |
| Operating expenses | $410.6M | $293.0M | $483.7M | $399.0M | $326.1M |
| Operating income | -$30.8M | $40.8M | -$203.4M | -$77.2M | -$29.7M |
| Pretax income | -$21.1M | $52.9M | -$190.1M | -$76.2M | -$32.1M |
| Income tax expense | $271,000 | $310,000 | $141,000 | $379,000 | -$1.4M |
| Net income | -$21.4M | $52.5M | -$190.3M | -$76.6M | -$30.7M |
| Balance Sheet | |||||
| Cash and equivalents | $65.4M | $114.7M | $82.2M | $89.9M | $348.5M |
| Current assets | $257.1M | $351.8M | $313.7M | $387.8M | $433.4M |
| Total assets | $413.2M | $491.1M | $466.8M | $543.0M | $566.6M |
| Current liabilities | $89.8M | $89.4M | $78.1M | $76.0M | $77.3M |
| Total liabilities | $110.1M | $112.6M | $205.5M | $112.1M | $100.7M |
| Stockholders' equity | $303.1M | $378.4M | $261.3M | $430.9M | $465.9M |
| Cash Flow Statement | |||||
| Cash from operations | $42.0M | $38.0M | -$18.4M | -$25.2M | -$19.3M |
| Depreciation and amortization | $15.0M | $14.2M | $14.4M | $11.6M | $8.8M |
| Stock-based compensation | $34.9M | $66.4M | $49.1M | $46.6M | $36.1M |
| Capital expenditure | $3.2M | $633,000 | $647,000 | $1.4M | $4.0M |
| Free cash flow | $38.8M | $37.4M | -$19.0M | -$26.7M | -$23.2M |
| Share repurchases | $87.8M | $522,000 | $27.5M | $642,000 | $0 |
| Impairments | $2.3M | $0 | $0 | $840,000 | $2.4M |
Shares outstanding 51.7M · Free float 85.4%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.